Radiation InjuriesAntineoplastic AgentsRadiation DosageRadiation, IonizingDose-Response Relationship, RadiationRadiation ToleranceRadiotherapyRadiotherapy DosageRadiationNeoplasmsCell Line, TumorCombined Modality TherapyDrug Screening Assays, AntitumorRadiation ProtectionRadiation OncologyRadiotherapy, ConformalRadiation MonitoringRadiotherapy, Intensity-ModulatedDoxorubicinDose FractionationApoptosisRadiotherapy Planning, Computer-AssistedRadiotherapy, AdjuvantRadiation PneumonitisCisplatinDrug Resistance, NeoplasmCell SurvivalRadiation-Sensitizing AgentsBrachytherapyDrug Delivery SystemsAntineoplastic Agents, PhytogenicRadiometryNeoplasms, Radiation-InducedGamma RaysRadiation Injuries, ExperimentalAntibiotics, AntineoplasticRadiosurgeryXenograft Model Antitumor AssaysTreatment OutcomeBrain NeoplasmsDrug CarriersMice, NudeBreast NeoplasmsTumor Cells, CulturedCosmic RadiationDNA DamageRadiotherapy, Computer-AssistedCell ProliferationAntineoplastic Combined Chemotherapy ProtocolsCranial IrradiationHead and Neck NeoplasmsEtoposidePaclitaxelParticle AcceleratorsNeoplasm Recurrence, LocalTime FactorsRadiotherapy, Image-GuidedDrug DesignRadiation-Protective AgentsBackground RadiationProstatic NeoplasmsEllipticinesFluorouracilRadiodermatitisDose-Response Relationship, DrugCamptothecinLung NeoplasmsUltraviolet RaysInhibitory Concentration 50Radiotherapy, High-EnergyAdenocarcinomaCarcinoma, Squamous CellMolecular StructureNeoplasm StagingTumor BurdenOrgans at RiskDrug Resistance, MultipleCell CycleP-GlycoproteinRadiation EffectsCobalt RadioisotopesDrug Evaluation, PreclinicalNanoparticlesClinical Trials as TopicMolecular Targeted TherapyRetrospective StudiesSurvival AnalysisNanomedicineDrug SynergismChemoradiotherapyDrug DiscoveryEnzyme InhibitorsGene Expression Regulation, NeoplasticProdrugsGlioblastomaDisease-Free SurvivalRadiobiologyAntimetabolites, AntineoplasticAntineoplastic Agents, AlkylatingSignal Transduction